Two Top Stocks To Ponder On: Nektar Therapeutics (NASDAQ:NKTR), Splunk Inc. (NASDAQ:SPLK)

Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR) closed at $20.11 on the last trading session with an increase of 0.85%, whereas, it previously closed at $19.94. The company has a market capitalization of $3.51 Billion. The company traded shares of 2.28 Million on the trading day while its three month average volume stands at 2.57 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Nektar Therapeutics (NASDAQ:NKTR) produced diluted EPS of -2.43. The EPS estimate for next year as estimated by analysts is at -2.5 while EPS for next quarter is estimated at -0.74. Earnings per Share growth for this year is reported at 289.5, while the analysts estimated the EPS growth for next year at -2.5% and Earnings growth for next 5 years stands at -7.3% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 36.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Nektar Therapeutics (NASDAQ:NKTR) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Nektar Therapeutics (NASDAQ:NKTR) stands at 29.47 and Price to Book or P/B for the most recent quarter stands at 2.25. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Nektar Therapeutics (NASDAQ:NKTR) are reported at 14 and 14.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Nektar Therapeutics (NASDAQ:NKTR) stands at -19.5, -25.2 and 34.9 respectively

The trailing twelve month Revenue of Nektar Therapeutics (NASDAQ:NKTR) is reported at 119.1 Million with income of -422700000. The outstanding shares of Nektar Therapeutics (NASDAQ:NKTR) are 174.55 Million. The institutional Ownership of the shares of 96.18 stands at 0.80%, this figure is increased 13.64 in the last six months. The insider ownership for the shares of Nektar Therapeutics (NASDAQ:NKTR) is ticked at 0.6%, the figure is plummeted -20.63% in the last six months.

Some other important financial aspects to be discussed here for Nektar Therapeutics (NASDAQ:NKTR) is the Mean Target Price estimated by the analysts which stands at 43.33. The 52 week high of Nektar Therapeutics (NASDAQ:NKTR) is placed at 63.78 and 52 week low is standing at 16.56.

Performance wise the shares of Nektar Therapeutics (NASDAQ:NKTR) rose up 18.22% for the week, it also rise 7.43% for the monthly performance, while for the quarter it went up -39.79%. The shares decrease -43.4% for the half year and plummeted for the Year-To-Date performance. The shares of Nektar Therapeutics (NASDAQ:NKTR) shrinked -67.99% for the yearly performance.

Splunk Inc. (NASDAQ:SPLK)

Splunk Inc. (NASDAQ:SPLK) closed at $113.65 on the last trading session with an decrease of -0.23%, whereas, it previously closed at $113.91. The company has a market capitalization of $17.24 Billion. The company traded shares of 1.17 Million on the trading day while its three month average volume stands at 1.91 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Splunk Inc. (NASDAQ:SPLK) produced diluted EPS of -2.08. The EPS estimate for next year as estimated by analysts is at 2.38 while EPS for next quarter is estimated at 0.54. Earnings per Share growth for this year is reported at -39.1, while the analysts estimated the EPS growth for next year at 2.38% and Earnings growth for next 5 years stands at 33.03% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -20.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Splunk Inc. (NASDAQ:SPLK) is at 0 while the forward p/e is at 47.79. The P/S or Price to Sales ratio of Splunk Inc. (NASDAQ:SPLK) stands at 8.43 and Price to Book or P/B for the most recent quarter stands at 11.91. The Price to Free Cash Flow ratio or P/FCF is reported at 339.36. The quick ratio and the current ratio of Splunk Inc. (NASDAQ:SPLK) are reported at 3.1 and 3.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Splunk Inc. (NASDAQ:SPLK) stands at -7.1, -21.4 and -8.4 respectively

The trailing twelve month Revenue of Splunk Inc. (NASDAQ:SPLK) is reported at 2.04 Billion with income of -309900000. The outstanding shares of Splunk Inc. (NASDAQ:SPLK) are 151.69 Million. The institutional Ownership of the shares of 94.2 stands at 0.80%, this figure is increased 0.33 in the last six months. The insider ownership for the shares of Splunk Inc. (NASDAQ:SPLK) is ticked at 0.8%, the figure is plummeted -12.13% in the last six months.

Some other important financial aspects to be discussed here for Splunk Inc. (NASDAQ:SPLK) is the Mean Target Price estimated by the analysts which stands at 150.44. The 52 week high of Splunk Inc. (NASDAQ:SPLK) is placed at 143.70 and 52 week low is standing at 83.69.

Performance wise the shares of Splunk Inc. (NASDAQ:SPLK) rose up 2.98% for the week, it also fell -9.51% for the monthly performance, while for the quarter it went up -3.88%. The shares decrease -10.74% for the half year and flew up for the Year-To-Date performance. The shares of Splunk Inc. (NASDAQ:SPLK) shrinked -9.76% for the yearly performance.